3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
HER2-positive Breast Cancer
1
Interventions
Trastuzumab
19
pyrotinib
14
pertuzumab
8
Docetaxel
7
Paclitaxel
6
Capecitabine
4
Carboplatin
3
neratinib
2
Protons
2
Neoadjuvant Therapy
2
Fulvestrant
2
Ado-Trastuzumab Emtansine
2
tucatinib
1
trastuzumab deruxtecan
1
pegfilgrastim
1
palbociclib
1
inavolisib
1
exemestane
1
envafolimab
1
dalpiciclib
1
atezolizumab
1
Taxoids
1
Metformin
1
Leuprolide
1
Letrozole
1
Isovaleryl-CoA Dehydrogenase
1
Goserelin
1
Genetic Testing
1
Fluorodeoxyglucose F18
1
Enfuvirtide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
HER2-positive Breast Cancer
×
Enfuvirtide
×
Clear all
NCT02379585
2018-04-24
STEFNE
Western Regional Medical Center
Phase 1/2
Terminated
8 enrolled
1 chart